Real-world Study on Adjuvant Octreotide Therapy in pNETs
NCT06080204
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
411
Enrollment
OTHER
Sponsor class
Conditions
Pancreatic Neuroendocrine Tumor G2
Interventions
DRUG:
Octreotide LAR
Sponsor
Changhai Hospital